
Xtalks Life Science Podcast
Xtalks
246 episodes listed below
PRESS PLAY
Find your next episode
In their own words
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
As heard by us
Based on 4 episodes we listened to · August 2026
A practical Science listen on how biotech research becomes treatments, companies, partnerships, and reimbursement problems.
Xtalks Life Science Podcast sits on the applied edge of the Science beat, where biomedical research runs into company strategy, clinical development, and health system constraints.
Why you'd press play
You want life science executives past the press-release glow and into reimbursement math.
Press play if you want
- biotech and biomedical leaders pressed on what slows progress down: payers, timelines, and consensus
- gene therapy talk that includes the multimillion-dollar bill, not just the miracle
Talks about
Podcasts like Xtalks Life Science Podcast
Flora Funga PodcastKK the Plant Biologist with a Thirst for MycologyMushroom culture from soil to society.
The Early PerspectiveClear neuroscience for curious minds.
Plants and PipettesPlant papers, jokes, and useful uncertainty.
AHRI SnapshotsWeed science, from genomes to paddocks.
Vanderbilt Beyond the Lab podcastBiomedical careers, described from the inside.
Sounds of ScienceHuman stakes behind biomedical progress.
Episodes
- 1
Teaching the Pancreas to Heal Itself: Dr. Juan Domínguez-Bendala on Regenerative Diabetes Research
·38m - 2
Scalable Biologics Production Trends: Featuring Omar Wahab of Lonza
·29m - 3
Novel Therapeutic and Trial Approaches for Lysosomal Storage Disorders with Polaryx’s Alex Yang
·40m - 4
Pioneering Biosensors for Continuous Medical Monitoring with Profusa CEO Dr. Ben Hwang
·47m - 5
Anti-Aging Gene Therapy in Alzheimer’s and ALS with Klotho Neurosciences’ Dr. Joseph Sinkule
·34m - 6
Translating Nerve Growth Factor Biology into Ocular Disease Therapies with Dompé’s Dr. Ahmed Enayetallah
·47m - 7
Fostering Collaboration to Accelerate Drug Discovery with the Chicago Biomedical Consortium’s (CBC) Dr. Michelle Hoffmann
·28m - 8
Targeting Protein Misfolding and Innovations in Hepatobiliary Disease with Rectify Pharma’s Dr. Pol Boudes
·40m - 9
Targeting Inflammation in Eye Diseases with Iolyx Therapeutics’ CEO Elizabeth Jeffords
·37m - 10
Innovative Approaches to Regenerative Therapies in Wound Care with BioStem CEO Jason Matuszewski
·37m - 11
Rare Disease Day Insight: Epilepsy Care Gaps in Pregnancy with UCB’s Andrea Wilkinson
·37m - 12
First Surrogate Endpoint in Osteoporosis Drug Trials with FNIH’s Dr. Tania Kamphaus
·39m - 13
Psilocybin Treatments for Treatment-Resistant Depression with Compass Pathways’ Dr. Steve Levine
·22m - 14
From Insights to Impact: Rare Disease Therapies with UCB’s Dr. Kim Moran
·43m - 15
The Biology of Aging: Innovations in Cellular Rejuvenation with Life Biosciences’ Dr. Sharon Rosenzweig-Lipson
·33m - 16
Advancing Rare Disease Treatment and Care with Takeda’s Dr. Mike Denne
·36m - 17
The Evolving Landscape of Respiratory and Immunology Drug Development with AstraZeneca’s Dr. Andrew Menzies-Gow
·39m - 18
Restoring Lost Synapses in ALS, Fragile X and More with Spinogenix’s Dr. Peter Vanderklish
·31m - 19
Off the Shelf Cell Therapies for Bone Marrow Transplantation with Ossium Health’s Kevin Caldwell
Hidden gemAisha Rashid interviews Kevin Caldwell, CEO, co-founder, and president of Ossium Health, about using cryopreserved bone marrow from deceased organ donors for allogeneic transplantation.
Apr 15, 2026·37m·2 clips - 20
Exploring the Future of Cannabinoid & Psychedelic Therapies with Joel Latham of Incannex Healthcare
Aisha Rashid interviews Joel Latham, CEO, President, and Director of Inconnex Healthcare, about cannabinoid pharmaceuticals and psychedelic therapies for obstructive sleep apnea, generalized anxiety disorder, and rheumatoid arthritis.
Sep 30, 2025·32m·2 clips - 21
Driving Innovation in Oncology: Insights from Jeff Glazier of General Oncology
Hidden gemJeff Glazier, CEO and founding member of General Oncology, describes moving from Harvard Law School and startup work into cancer drug development after his aunt Sharon’s pancreatic cancer treatment.
Sep 24, 2025·34m·2 clips - 22
The Next Generation of Cell Therapy with Cartherics’ COO Dr. Ian Nisbet
Hidden gemXtalks Life Science Podcast host Aisha Rashid interviews Cartherics COO and co-founder Dr.
Sep 17, 2025·56m·3 clips - 23
Why MASH Matters: The Next Steps in Liver Disease Innovation with 89bio’s Rohan Palekar
Hidden gemRohan Palekar, CEO of 89Bio, explains how MASH progresses from liver fat and inflammation to fibrosis and cirrhosis, with U.S.
Sep 10, 2025·36m·2 clips - 24
Bridging Aesthetics and Therapeutics in Dermatology with Galderma’s Dr. Bill Andriopoulos
Interview with Dr.
Sep 3, 2025·36m - 25
The Neuroscience of Weight Regulation with Courage Therapeutics’ Dr. Roger Cone
Aisha Rashid interviews Roger Cohn, founder of Courage Therapeutics and University of Michigan professor, about MC3R and MC4R pathways regulating hunger, energy storage, and body weight.
Aug 27, 2025·51m·3 clips - 26
Exploring Immunomodulation Without Immunosuppression with Artax Biopharma’s Dr. Rob Armstrong
Aisha Rashid interviews Artax Biopharma CEO Dr.
Aug 19, 2025·38m·2 clips - 27
Advancing Neurotherapeutics for Fragile X and Beyond with Spinogenix CMO Dr. Craig Erickson
Dr.
Aug 13, 2025·37m·2 clips - 28
Driving Neuro Innovation with Neurizon Therapeutics CEO Dr. Michael Thurn
Hidden gemXtalks Life Science Podcast host Aisha Rashid interviews Neurizon Therapeutics CEO Dr.
Aug 6, 2025·44m·3 clips - 29
Restoring Synapses to Fight ALS, Alzheimer’s and More with Spinogenix CEO Dr. Stella Sarraf
Hidden gemDr.
Jul 30, 2025·39m·2 clips - 30
Championing the Patient Voice with Ardelyx’s Chief Patient Officer Dr. Laura Williams
Hidden gemDr.
Jul 23, 2025·38m·2 clips - 31
Inside AI-Powered Drug Discovery with Gain Therapeutics’ CEO Gene Mack
Hidden gemGene Mack, CEO and President of Gain Therapeutics, explains the company’s effort to develop disease-modifying therapies for Parkinson’s disease and other neurodegenerative conditions.
Jul 16, 2025·31m·2 clips - 32
Targeting Mast Cells: A New Frontier in Allergy & Inflammation with Jasper Therapeutics’ CMO Dr. Edwin Tucker
Hidden gemJasper Therapeutics CMO Dr.
Jul 9, 2025·38m·2 clips - 33
Reprogramming Cancer: A New Era of AI-Powered Immunotherapy with CancerVax’s Adam Grant
Hidden gemAyesha Rishi interviews CancerVax Principal Scientist Adam Grant about a Universal Cancer Treatment Platform that uses marker-one targeting and smart mRNA to make cancer cells resemble viruses such as measles.
Jul 2, 2025·49m·3 clips - 34
Understanding Desmoid Tumors: Insights from Dr. Alessandra Maleddu, Sarcoma Specialist at University of Colorado
Jun 25, 2025·22m - 35
Advancing Dendritic Cell Immunotherapy for Glioblastoma: Insights from Diakonos Oncology’s Jay Hartenbach
Jun 18, 2025·21m - 36
Pioneering A New Era of T-Cell Immunotherapy with CERo Therapeutics’ CEO Chris Ehrlich
Jun 11, 2025·27m - 37
Radiopharmaceuticals and the Future of Nuclear Medicine with RadioMedix CEO Dr. Ebrahim Delpassand
May 21, 2025·38m - 38
Building the Future of Brain Health: Neuroscience Drug Development with Novartis’ Dr. Norman Putzki
May 14, 2025·28m - 39
Rare Disease Innovation in an Evolving Industry with Amgen’s Dr. Sumita Bhatta
May 7, 2025·32m - 40
Advancing Novel Immunotherapy Approaches for Osteosarcoma and Beyond with Paul Romness, CEO of OS Therapies
Apr 30, 2025·43m - 41
Targeting the Cell’s Powerhouse: Dr. Shaharyar Khan on Rivus Pharma’s Mitochondrial Approach to Cardiometabolic Diseases
Apr 23, 2025·42m - 42
Inside the Latest in Targeted Radiotherapeutics with Plus Therapeutics CEO Dr. Marc Hedrick
Apr 16, 2025·47m - 43
From Lab to Launch: Commercializing Gene Therapies for Rare Diseases with Rocket Pharma’s Carlos Martin
Apr 9, 2025·34m - 44
Combating Autoimmunity: Vera Therapeutics CEO Dr. Marshall Fordyce Discusses Advancing IgAN Treatments
Apr 2, 2025·45m - 45
Targeting Pressing Unmet Needs in Kidney Diseases with Unicycive Therapeutics CEO Dr. Shalabh Gupta
Mar 26, 2025·40m - 46
Innovating Treg Therapies for ALS and Alzheimer’s with Coya Therapeutics CEO Dr. Arun Swaminathan
Mar 19, 2025·39m - 47
The Path to Healthy Aging: Pioneering Therapies for Age-Related Diseases with Rejuvenate Biomed's Ann Beliën
Mar 12, 2025·27m - 48
Driving Innovations in Rare Diseases with Takeda’s Anthea Cherednichenko
Feb 26, 2025·30m - 49
Advancing Alzheimer’s Diagnostics: Insights from ALZpath VP of R&D Dr. Lee Honigberg on the Future of Blood-Based Biomarker Assays
Feb 19, 2025·33m - 50
Advancing PTSD Treatment with Digital Brain Biomarkers ft. Oded Kraft, Co-Founder, CEO and President of GrayMatters Health
Feb 12, 2025·25m - 51
Innovating Immune-Modulating Therapies in Autoimmune Disorders ft. Dr. Mario Marcondes, VP Head of Clinical Development, Nektar Therapeutics
Feb 5, 2025·40m - 52
Advancing Digital Approaches in Alzheimer’s Research and Care ft. Sarah Averill Lott, Research Lead, Digital Medicine Society (DiMe) & Diane Stephenson, Executive Director, Critical Path for Parkinson
Jan 29, 2025·49m - 53
Transformative Neuropsychiatric Therapies ft. Dr. Amit Etkin, Founder, President and CEO of Alto Neuroscience
Jan 22, 2025·31m - 54
Pioneering Cancer Treatment with Alpha Radiation Technology ft. Alpha Tau Medical CMO Dr. Robert Den
Jan 15, 2025·22m - 55
Innovations in Immunomodulators for Diseases of the Immune System ft. Dr. Judy Chou, CEO, AltruBio
Jan 8, 2025·35m - 56
Innovating Cell-Based Solutions for Type 1 Diabetes ft. Jonathan Rigby, CEO, Sernova
Dec 18, 2024·48m - 57
Immune-Based Intratumoral Cancer Therapies ft. Intensity Therapeutics founder and CEO Lewis Bender
Dec 12, 2024·42m - 58
Targeting Cancer Drug Resistance with Kairos Pharma’s CEO Dr. John Yu
Dec 4, 2024·28m - 59
Innovating Immunotherapeutics with Oncolytic Virus Therapy ft. Oncolytics Biotech’s CMO Dr. Thomas Heineman
Nov 27, 2024·46m - 60
Laser Vision: Pioneering Laser Innovations for Presbyopia ft. Ace Vision’s Dr. AnneMarie Hipsley
Nov 20, 2024·45m - 61
Bringing the Tech Revolution to Medicine with Digital Therapeutics ft. Click Therapeutics’ CMO Dr. Shaheen Lakhan
Nov 13, 2024·1m - 62
Inside the Latest Advances in Hearing Tech ft. Envoy Medical CEO Brent Lucas
Nov 6, 2024·37m - 63
Advances in Heart Failure Treatment ft. Dr. Robert Perkins, VP, US Medical Affairs/Renal, Bayer
Oct 31, 2024·20m - 64
Transforming Clinical Research: A Conversation with Morgan Hanger, Executive Director of CTTI
Oct 23, 2024·29m - 65
Innovative Approaches to Antiviral Drug Development
Oct 16, 2024·33m - 66
A Unique Approach to in vivo CAR T Therapy and New Advancements in the Field
Oct 9, 2024·32m - 67
The Promise of Epigenetic Therapeutics in Alcohol-Associated Hepatitis ft. DURECT President and CEO Dr. James Brown
Oct 2, 2024·33m - 68
Pioneering mRNA Therapies for Lung Diseases
Sep 25, 2024·34m - 69
Silencing Disease: Shifting Treatment Paradigms with RNAi Therapeutics ft. Alnylam’s VP Research Dr. Kirk Brown
Sep 18, 2024·30m - 70
The Science of Sleep: Unmet Needs and Treatments for Narcolepsy ft. Avadel Pharma’s Dr. Jennifer Gudeman
Sep 4, 2024·34m - 71
Non-Hormonal Innovations in Obesity and Diabetes Treatment with Aphaia Pharma’s Dr. Steffen-Sebastian Bolz
Aug 28, 2024·43m - 72
FNIH Study Shows Promise of Blood Tests for Alzheimer’s Disease, featuring Dementia Expert Dr. Schindler and FNIH Neuroscience Director Dr. Travaglia
Aug 21, 2024·37m - 73
Beyond the Beat: Dr. Matthew Martinez Discusses HCM Care in Athletes and New Camzyos Guidelines
Aug 14, 2024·39m - 74
Bridging Science and Advocacy with Lawreen Asuncion, Life Science Professional and Rare Disease Patient Advocate
Aug 7, 2024·34m - 75
Bringing Integrated Nutritional and Pharmaceutical Approaches to the Table for GI Health with Nestlé Health Science’s Moreno Perugini
An interview with the President of Nestle Health Science about pharmaceutical therapies and gut health treatments.
Jul 31, 2024·36m - 76
Innovating Approaches to Target Diseases of Aging with Jerry McLaughlin, CEO of Life Biosciences
Interview with Jerry McLaughlin, CEO of Life Biosciences, discussing their gene therapy for optic neuropathies and cellular rejuvenation to reverse aging diseases.
Jul 24, 2024·30m - 77
Golden Innovations: Nanocrystal Therapies for ALS and MS with Clene Nanomedicines’ Dr. Karen Ho
An interview with Dr.
Jul 16, 2024·34m - 78
From Symptoms to Solutions: Transforming Menopause Treatment with Marci English of Astellas Pharma
Interview with Marcy English about the FDA-approved drug Fezolinitin for menopause symptoms.
Jul 10, 2024·28m - 79
New Frontiers in MASH and Chronic Liver Diseases with Aligos CEO Dr. Lawrence Blatt
Jul 3, 2024·35m - 80
FNIH’s Dr. Travaglia and ALS Patient Advocate Dr. Sethi Discuss New ALS Program
Jun 26, 2024·30m - 81
The Road Ahead for Former ALS Hopeful Relyvrio ft. Amylyx's Joshua Cohen and Justin Klee
Jun 19, 2024·41m - 82
Insights into Precision Dosing with Dr. Howard McLeod and Dr. Sharmeen Roy
Jun 12, 2024·39m - 83
Targeting AML with a New Generation of T-Cell Therapies, ft. Brian Atwood, Chairman and CEO of CERo Therapeutics
Jun 5, 2024·30m - 84
Exploring Next-Gen Antivirals ft. Sam Lee, PhD, Co-CEO & President, Cocrystal Pharma
May 29, 2024·25m - 85
Gene Editing Innovations with Programmable Gene Insertion (PGI) Technology ft. Dr. John Finn, Tome Biosciences
May 22, 2024·34m - 86
New Frontiers in Epilepsy and Seizure Treatments ft. Dr. Jeremy Levin and Meg Alexander, Ovid Therapeutics
May 15, 2024·48m - 87
The State of Infectious Diseases and New Trivalent Flu Vaccine ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore
May 8, 2024·49m - 88
Psychedelic-Based Therapeutics for Generalized Anxiety Disorder (GAD) – Interview with Robert Barrow, CEO, MindMed
May 1, 2024·26m - 89
Developing Conditionally Active Antibodies: Interview with John K. Celebi, President & CEO, Sensei Bio.
Apr 24, 2024·28m - 90
Treg Cell Therapy for Neurodegenerative Diseases – Interview with Dr. Howard Berman, CEO, Coya Therapeutics
Apr 17, 2024·34m - 91
Improving Cancer Screening Among Métis Communities: Interview with Margaret Froh, President, Métis Nation of Ontario
Apr 10, 2024·32m - 92
Cell Therapies for Chronic Kidney Disease: Featuring Bruce Culleton, CEO, ProKidney
Apr 3, 2024·26m - 93
Tackling Diabetic Kidney Disease: Featuring Robert Perkins, VP, US Medical Affairs (Renal), Bayer
Mar 27, 2024·18m - 94
People in Life Sciences Series: Day-in-the-Life of a Pharmacovigilance Professional – Interview with Ashish Jain, Senior Director of Clinical Safety a...
Mar 20, 2024·34m - 95
Building Cancer Awareness and Empowering Métis Youth: Featuring Jordyn Playne, President, Métis Nation of Ontario Youth Council
Mar 13, 2024·19m - 96
Transforming Eye Care: Innovating New Glaucoma and Dry Eye Disease Treatments
Mar 6, 2024·24m - 97
Rare Disease Day 2024: Highlighting Patient Stories and Advancements in Rare Disease Research
Feb 28, 2024·34m - 98
Biologics Development in Immunology and Inflammation — Featuring Amir Reichman, CEO of Scinai Immunotherapeutics
Feb 21, 2024·25m - 99
Novel Approaches in Cancer Immunotherapy — Featuring OncoC4 founder, CEO and CSO Dr. Yang Liu and CFO Abid Ansari
Feb 14, 2024·25m - 100
New Targeted Treatments for Breast Cancer — Conversation with Dr. Carlos Doti, VP, US Medical Affairs Oncology, AstraZeneca
Feb 7, 2024·22m - 101
Untitled Episode
Feb 7, 2024·23m - 102
Exploring the Endocannabinoid System for Drug Development, Featuring Punit Dhillon, Chairman & CEO of Skye Bioscience
Jan 31, 2024·25m - 103
Life Science Trends for 2024
Jan 24, 2024·43m - 104
Revolutionizing Orthopedic Joint Replacement — Interview with Ben Sexson, Co-Founder, CEO, Monogram Orthopedics
Jan 17, 2024·37m - 105
Cognitive and Neuropsychiatric Disorders Drug Development, Featuring Dr. Adam Kaplin, Cofounder, President, CSO, MIRA Pharmaceuticals
Jan 10, 2024·57m - 106
Pneumococcal Vaccination for Adults: Conversation with Vaccine Scientists Dr. Heather Platt and Dr. Ulrike Buchwald from Merck
Dec 13, 2023·44m - 107
A Focus on Men’s Health — Conversation with Fady Boctor, Petros Pharma President and CCO
Dec 6, 2023·23m - 108
“Off-the-Shelf” Cellular Therapy: Interview with Longeveron CEO Wa’el Hashad
Nov 29, 2023·34m - 109
Attorney Tope Leyimu Discusses Proposed FDA ban on Hair Relaxer Products Containing Harmful Chemicals
Nov 22, 2023·21m - 110
Dr. Lahar Mehta Speaks About New Trial to Evaluate ALS Drug for Progressive Supranuclear Palsy
Nov 15, 2023·26m - 111
FDA Considers Self Administered Nasal Flu Vaccine + Wayne Gretzky Features in GSK RSV Vaccine Ad
Nov 8, 2023·32m - 112
Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allerga...
Nov 1, 2023·33m - 113
Lead Investigator Dr. Genevieve Neal-Perry Discusses New Trial Data for Astellas’ Menopause Drug Fezolinetant (Veozah)
Oct 25, 2023·22m - 114
Johnson & Johnson Faces Lawsuit Over Patient Data Breach + Sleepiz’s Sleep Monitoring Device Gets FDA Clearance
Oct 18, 2023·26m - 115
Advancing CAR T Cell Therapies in Immuno-Oncology – Featuring Dr. Paul Rennert, CEO, CSO, Aleta Biotherapeutics
Oct 11, 2023·48m - 116
New HPV Vaccine Data Shows Long-Term Impact – Featuring Dr. Elmar Joura from the Medical University of Vienna
Oct 4, 2023·20m - 117
Interview with Dr. Kristin Yarema, President of Cell Therapy at Poseida Therapeutics
Sep 27, 2023·34m - 118
Advancements in Blood-Based Biomarker Tests for NASH — Interview with Dr. Tania Kamphaus and Tony Villiotti
Sep 20, 2023·42m - 119
Insights into New Alzheimer’s Treatments: Treating Agitation and First THC-Based Therapeutic in Trials — Interview with IGC’s Ram Mukunda and Claudia ...
Sep 13, 2023·35m - 120
Discussing Next Generation Chemotherapy Drugs with Processa Pharma’s Dr. David Young
Sep 6, 2023·31m - 121
More US States Take on Eli Lilly in Court Over Proposed Insulin Pricing Settlement + Regeneron’s High Dose Eylea Wins FDA Approval
Aug 30, 2023·25m - 122
Interview with BriaCell’s CEO Dr. William Williams
Aug 23, 2023·25m - 123
First Oral Tablet for Postpartum Depression + Court Rejects JJ’s Latest Bankruptcy Attempt
Aug 16, 2023·30m - 124
FDA Clearances for World’s Smallest Insulin Pump + New Cardiac Biomarker Test
Aug 9, 2023·23m - 125
In Conversation with Principal Investigator and SME Dr. Lawrence Eichenfield About the FDA Approval of a Drug-Device Combo for Common Skin Infection
Aug 2, 2023·23m - 126
Point-of-Care Testing for Infectious Diseases: Senzo CEO Jeremy Stackawitz Speaks About Company’s New Lateral Flow Technology
Jul 26, 2023·56m - 127
Biosimilars and the Problem with PBMs: Interview with Juliana M. Reed, Executive Director of the Biosimilars Forum
Jul 19, 2023·36m - 128
Opioid Use Disorder and Brixadi Approval: Interview with Dr. Joshua Cohen, Chief Medical Officer at Braeburn
Jul 12, 2023·15m - 129
Developing More Affordable Cellular Immunotherapies: Interview with CytoMed Therapeutics
Jul 5, 2023·28m - 130
Xtalks Speaks with Astellas Pharma’s VP & Head of BioPharma Development Marci English About Menopause Drug Approval
Jun 28, 2023·20m - 131
Wireless Charging for Medical Devices: Interview with Resonant Link’s CEO and Co-Founder Dr. Grayson Zulauf
Jun 21, 2023·27m - 132
In conversation with FNIH’s Dr. Courtney Silverthorn, Director of the AMP Bespoke Gene Therapy Consortium, About New Rare Disease Trial Portfolio
Jun 14, 2023·25m - 133
AI and ChatGPT for Medical Record Management: Interview with Carm Huntress, CEO and Founder of Credo Health
Jun 7, 2023·39m - 134
First Topical Gene Therapy + Bausch + Lomb’s First Prescription Med for Dry Eye
May 31, 2023·26m - 135
First Topical Gene Therapy + Bausch + Lomb's First Prescription Med for Dry Eye
May 31, 2023·32m - 136
Veozah the New Drug for Menopausal Hot Flashes + SkinVive the New Dermal Filler
May 25, 2023·42m - 137
Interview with Dr. Gillian Woollett, VP, Head of Regulatory Strategy and Policy at Samsung Bioepis
May 17, 2023·27m - 138
World’s First RSV Vaccine + First Novel Treatment for ALS
May 10, 2023·23m - 139
Axonics’ Non-Drug Incontinence Therapy + How AI Can Be Used to Study the Side Effects of Drugs
May 3, 2023·38m - 140
Interview with Cody Simmons, CEO of DermaSensor, Maker of a Handheld Skin Cancer Evaluation Tool
Apr 26, 2023·35m - 141
EPA Proposes Stricter Ethylene Oxide Limits + Johnson and Johnson Offers $8.9 Billion Settlement
Apr 19, 2023·36m - 142
Interview with Wei-Li Shao, President Virtual Care Company Omada Health
Apr 12, 2023·29m - 143
Pharma By The Numbers: Celebrating 20 Years of Xtalks with an Analysis of the Industry
Apr 5, 2023·56m - 144
Interview with Definitive Healthcare’s VP, Head of Healthcare Consulting, Manu Garg, about Healthcare Commercial Intelligence
Mar 29, 2023·20m - 145
Interview with Tidepool’s CEO and Co-Founder Howard Look About an Automated Insulin Dosing App for Type 1 Diabetes
Mar 22, 2023·34m - 146
Interview with Neuromod COO Diarmuid Flavin About the FDA Approval of Tinnitus Treatment Lenire
Mar 15, 2023·25m - 147
FDA approval of First Geographic Atrophy Treatment and Authorization of First At-Home Combo COVID-19 and Flu Test
Mar 8, 2023·41m - 148
Interview with Cala Health’s CCO Doug Biehn about Neuromodulation Therapy Cala Trio for Hand Tremors
Mar 1, 2023·20m - 149
Sunrise’s At-Home Sleep Apnea Test Gets FDA Clearance + BMS-Pfizer Team up with Kareem Abdul Jabbar for AFib Awareness
Feb 22, 2023·29m - 150
Interview with Polarean Imaging CTO Dr. Bastiaan Driehuys on the FDA Approval of Lung Imaging Drug Device Combo Xenoview
Feb 15, 2023·33m - 151
Amgen Launches Humira Biosimilar Amjevita + Potential New Blood Test for Early Detection of Alzheimer’s
Feb 8, 2023·33m - 152
Amazon’s New $5 Prescription Drug Program + Top 10 Pharma TV Ad Spenders in 2022
Feb 1, 2023·32m - 153
Interview with Thea Pharma’s Susan Benton about Eye Care and the FDA Approval of Iyuzeh
Jan 25, 2023·29m - 154
XBB.1.5 Omicron Subvariant + FDA Approves AstraZeneca’s New Asthma Inhaler
Jan 18, 2023·32m - 155
Interview with Breast Surgical Oncologist Dr. Monique Gary on Cancer Health Disparities
Jan 11, 2023·26m - 156
Life Science Trends for 2023
Jan 4, 2023·36m - 157
Interview with the leaders at Amylyx, Maker of New FDA Approved ALS Drug Relyvrio
Dec 14, 2022·26m - 158
FDA Approves First Fecal Matter Therapy + PureTech Reveals New CBD Oral Capsule
Dec 7, 2022·23m - 159
First Gene Therapy Approved for Hemophilia B + World AMR Awareness Week
Nov 30, 2022·35m - 160
FDA Approves First Drug to Delay T1D + Positive Data for Pfizer’s Maternal RSV Vaccine
Nov 23, 2022·23m - 161
Novo Nordisk’s Ozempic (Semaglutide) Shortage and Fake Eli Lilly Twitter Account Announces Free Insulin
Nov 16, 2022·29m - 162
Interview with Eye Health Biotech Santen Pharmaceuticals’ CMO Peter Sallstig
Nov 9, 2022·22m - 163
FDA Approves Immunotherapies for Multiple Myeloma and Liver Cancer
Nov 2, 2022·27m - 164
Interview with Cystic Fibrosis and Rare Disease Patient Leader Gunnar Esiason
Oct 26, 2022·31m - 165
Elon Musk Reveals he Used Novo’s Wegovy for Weight Loss + FDA Approval of Nevro’s AI Spinal Cord Stimulation System
Oct 19, 2022·28m - 166
Bimodal Neuromodulation for Tinnitus: Interview with Caroline Hamilton, Clinical Director of Neuromod Devices – Xtalks Life Science Podcast Ep. 81
Oct 12, 2022·23m - 167
The Neurolenses Solution for Digital Vision Syndrome: Interview with Pierre Bertrand, CEO of Neurolens
Oct 5, 2022·25m - 168
FDA Approves World’s Most Expensive Gene Therapy for Rare Disease + CDC Concerned About New COVID-19 Variant
Sep 28, 2022·28m - 169
How Air Pollution Triggers Lung Cancer + Scientists Develop Parkinson’s Test Based on Woman’s Ability to Smell It
Sep 21, 2022·28m - 170
FDA Approval of Sanofi’s Enzyme Replacement Drug for ASMD + Disney Actress Partners with Medtronic for Diabetes Tech Campaign
Sep 14, 2022·25m - 171
Fitbit Introduces New Smartwatch with AFib Detection + FDA Approves Imbruvica for Pediatric Patients with cGVHD
Sep 7, 2022·24m - 172
FDA Approval of First Rapid-Acting Oral Depression Drug + Approval of $2.8 Million Gene Therapy for Rare Blood Disorder
Aug 31, 2022·27m - 173
Interview with Asaf Zviran, CEO of Cancer Genomics Company C2i Genomics
Aug 24, 2022·25m - 174
UK Approves First Omicron-Targeting COVID Vaccine + National Immunization Awareness Month
Aug 17, 2022·25m - 175
New COVID-19 Testing Technology + FDA Approves First Drug for HER2-Low Breast Cancer
Aug 10, 2022·23m - 176
FDA Approvals for Liquid Epilepsy Drug and a Vitiligo Medication
Aug 3, 2022·23m - 177
Towards a ’Functional Cure’ for Diabetes with Dr. Philip Toleikis, CEO, Sernova Corp
Jul 27, 2022·38m - 178
Expanded Approval for Gout Drug + Novavax COVID-19 Vaccine Gets FDA Authorization
Jul 20, 2022·28m - 179
FDA Issues Safety Warning for Blood Cancer Drug + Long COVID Risk Assessment Tool
Jul 13, 2022·23m - 180
BD Develops New Monkeypox Test + FDA Authorizes COVID-19 Vaccines for Infants
Jul 6, 2022·26m - 181
Eli Lilly’s Olumiant FDA Approved for Alopecia + Alnylam’s RNAi Drug Amvuttra Approved for Rare Protein Disorder
Jun 22, 2022·24m - 182
More Positive Data for Tirzepatide Weight Loss Injection + Sandoz’s Global Biosimilars Awareness Campaign
Jun 15, 2022·23m - 183
Interview with Georgia Tech’s Dr. Woon-Hong Yeo About a New Smart Stent Platform for Wireless Vascular Monitoring
Jun 8, 2022·23m - 184
Interview with Dr. Samantha Dale Strasser, CSO and Co-Founder of Transomics Drug Discovery Start-Up ”Pepper Bio”
Jun 1, 2022·27m - 185
FDA Approves New Type 2 Diabetes Injection Mounjaro + US Reports First Case of Monkeypox
May 25, 2022·25m - 186
Messaging Program Improves Lifestyle Among Heart Attack Survivors + FDA Places Stricter Restrictions on Janssen COVID-19 Vaccine
May 18, 2022·25m - 187
FDA Approves Bristol Myers’ Cardiac Drug for HCM + New Ovarian Cancer Blood Test
May 11, 2022·28m - 188
First FDA-Approved Treatment for Chronic Yeast Infection + Eli Lilly Obesity Drug Shows Promise in Trials
May 4, 2022·31m - 189
World Immunization Week 2022 + New COVID-19 Breath Test Gets FDA Authorization
Apr 27, 2022·25m - 190
BioNTech Partners for mRNA Vaccine Delivery Tech + Pfizer Acquires ReViral for RSV Therapeutics
Apr 20, 2022·24m - 191
Statins May Lower Parkinsonism Risk + New Genetic Test to Prevent Deafness in Babies
Apr 13, 2022·28m - 192
Clinical Trial Diversity Insights from NIH Experts + WHO and Polluted Air on World Health Day 2022
Apr 6, 2022·37m - 193
Pfizer Recalls Blood Pressure Medication + Jazz Pharma Manufacturing Cannabis-Based Medications
Mar 30, 2022·24m - 194
Exact Sciences and Katie Couric’s Colon Cancer Awareness TV Ad + Alnylam Sues Pfizer and Moderna Over Patent Infringements
Mar 23, 2022·24m - 195
Johnson & Johnson Funding Human Asbestos Studies + Swift Medical’s Imaging Device for Remote Digital Wound Care
Mar 16, 2022·28m - 196
Celebrating Women’s Leadership in Life Sciences on International Women’s Day + Johnson & Johnson’s Cell Therapy for Multiple Myeloma Gets FDA Approval
Mar 9, 2022·33m - 197
Marking Rare Disease Day 2022 by Sharing Colours + Why Black People Remain Underrepresented in Clinical Trials
Mar 2, 2022·47m - 198
BioNTech Unveils Modular mRNA Factories for Africa + FDA Authorizes Eli Lilly Monoclonal Antibody Effective Against Omicron
Feb 23, 2022·26m - 199
UK’s NHS Backs World’s Costliest Drug for Treatment of MLD + Report Finds Increase in Pharma Cybersecurity Threats
Feb 16, 2022·26m - 200
Inbody’s At-Home Real Time Blood Pressure Monitoring + Eli Lilly Announces Investments into New Manufacturing Facilities
Feb 9, 2022·24m - 201
FDA Approval for First TCR Therapy for Uveal Melanoma + Pfizer and Moderna Begin Trials for Omicron Booster
Feb 2, 2022·24m - 202
Gilead Sues Over Counterfeit HIV Drugs + Menarini’s New Rapid COVID-19 PCR Test
Jan 26, 2022·30m - 203
Study Shows Exercise Can Maintain Cognitive Health in Elderly + Abbott’s New Cardiac Mapping System
Jan 19, 2022·23m - 204
New Cancer Blood Test + Bayer Commits to All Green Packaging by 2030
Jan 12, 2022·29m - 205
FDA and CDC Update Guidelines Amid Omicron + Life Science Trends for 2022
Jan 5, 2022·31m - 206
Biohaven Intranasal Migraine Drug Gets FDA Approval + Moderna’s mRNA Influenza Vaccine
Dec 15, 2021·31m - 207
Moderna and Pfizer Premature Statements on Omicron + FDA Approves New Hepatitis B Vaccine
Dec 8, 2021·28m - 208
WHO Declares Omicron Variant of Concern + Seizure Drug Recalled Over Faulty Seal
Dec 1, 2021·34m - 209
Virtual Reality Treatment for Chronic Pain + Canadian CDMO Biovectra to Build mRNA Manufacturing Plant
Nov 24, 2021·29m - 210
Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression
Nov 17, 2021·25m - 211
Pfizer’s COVID-19 Antiviral Pill + FDA Approves AbbVie’s Eyedrop for Presbyopia
Nov 10, 2021·32m - 212
FDA Authorizes Pfizer COVID-19 Vaccine for Children 5 to 11 + Genentech’s Drug Delivery System for Macular Degeneration
Nov 3, 2021·34m - 213
FDA Approves Interchangeable Humira Biosimilar + Gene Silencing Treatment for Porphyria Gets Nod From England’s NICE
Oct 27, 2021·36m - 214
Moderna Unwilling to Share COVID-19 Recipe + Singer Mary J Blige Partners with Hologic for Breast Cancer Awareness
Oct 20, 2021·48m - 215
Researchers Develop Arthritis Vaccine + Medtronic Expands Recall on Insulin Pumps
Oct 13, 2021·28m - 216
CDC Says Flu and COVID-19 Shots Can Be Co-Administered + Merck’s Oral Antiviral for COVID-19 Shows Stellar Results
Oct 6, 2021·28m - 217
New FDA ”Bad Ad” Quiz + Pfizer COVID-19 Vaccine Data for Young Children
Sep 29, 2021·29m - 218
FDA on COVID-19 Vaccine Boosters + Advocacy Group Pushes for Speedy FDA Approval of ALS Drug
Sep 22, 2021·35m - 219
Eli Lilly to Develop RNA Editing Therapies + Study Shows Benefits of Daily Steps
Sep 15, 2021·24m - 220
World’s First Smart Knee + Alzheimer’s Blood Test
Sep 8, 2021·22m - 221
Why Antimicrobial Resistance is a Silent Pandemic
Sep 1, 2021·23m - 222
How the Approval of Aducanumab Will Change Alzheimer’s Trials
Aug 25, 2021·28m - 223
FDA Authorizes COVID-19 Vaccine Boosters for Immunocompromised Individuals
Aug 18, 2021·29m - 224
AAIC 2021 – COVID-19 Impacts on Cognitive Health + Pancreatic Cancer Blood Test
Aug 11, 2021·30m - 225
AAIC 2021 - Diversity in Clinical Trials + Johnson & Johnson Sued by Black Women’s Group
Aug 4, 2021·43m - 226
AAIC 2021 – Aduhelm Recommendations + Pfizer’s Expanded Chantix Recall
Jul 28, 2021·39m - 227
WHO Comments on COVID-19 Vaccine Mixing + World’s First Glucose Saliva Test
Jul 21, 2021·39m - 228
Nestlé to Market Oral Microbiome Drug for C. Difficile + WHO Recommends IL-6 Blockers as Life-Saving COVID-19 Treatment
Jul 14, 2021·40m - 229
First FDA-Approved Video Game for ADHD + Why Not to Worry About Menstrual Changes After COVID-19 Vaccination
Jul 7, 2021·37m - 230
NeuraLace’s Peripheral Nerve Stimulation System for Chronic Pain + AstraZeneca Fights COVID Vaccine Delivery Lawsuit
Jun 30, 2021·25m - 231
Measuring Body Fat Percentage with Amazon’s Halo app + Regeneron’s Antibody Treatment Cuts Risk of COVID-19 Deaths
Jun 23, 2021·32m - 232
World’s First Digital Fabric + Amazon’s Direct-to-Consumer COVID-19 Test
Jun 16, 2021·31m - 233
Fruit and Type 2 Diabetes Risk + Moderna’s Manufacturing Partnerships
Jun 9, 2021·29m - 234
Google’s AI Dermatology App + WHO’s Investigations into the Coronavirus Lab Leak Theory
Jun 2, 2021·32m - 235
Clinical Trials Day 2021 + AbbVie’s Humira Monopoly
May 26, 2021·33m - 236
Pharma TV Ad Spending Trends + AI Algorithm for Heart Disease
May 19, 2021·24m - 237
Epigenetic Editing with CRISPR + ADHD in Preschoolers
May 12, 2021·37m - 238
At-Home Sleep Apnea Test + Neurological Rehabilitation Device for Stroke Patients
May 5, 2021·30m - 239
Malaria Vaccine + Sugar’s Effect on Brain Development in Children
Apr 28, 2021·36m - 240
J&J COVID-19 Vaccine and Thrombosis + Medtronic’s Harmony Transcatheter Pulmonary Valve Approval
Apr 21, 2021·35m - 241
Parkinson’s Disease: Link With Melanoma + Drug Development
Apr 14, 2021·33m - 242
Social Media’s Disinformation Dozen + Pfizer’s Latest COVID-19 Vaccine Trial Results
Apr 7, 2021·27m - 243
Caffeine Consumption in Pregnancy + Portable Neuromodulation Stimulator for MS
Mar 31, 2021·28m - 244
Why You Can’t Compare COVID-19 Vaccine Efficacies
Mar 24, 2021·23m - 245
Mask-Associated Dry Eye + Droplet Micron Insulin Needle
Mar 24, 2021·28m - 246
COVID-19 Pandemic Anniversary + Cancer Biotech Acquisitions
Mar 24, 2021·40m